Trial Parameters
Brief Summary
The aim is to record and document a mediastinal PT and the corresponding follow-up data (effectiveness and side effects). General recommendations for planning and feasibility are made within the framework of this study.
Eligibility Criteria
Inclusion Criteria: Histologically confirmed lymphoma according to WHO * Patient consent * Patient age ≥18 years. * Presence of the need for mediastinal radiotherapy and the presumed benefit of mediastinal radiotherapy using protons in comparison to photon radiation (e.g. improved heart, lungs, and breast protection compared to photon radiation). * Ability of the patient to give consent Exclusion Criteria: Age \<18 years * Non-consent of the patient to the disclosure of his data * Cancellation of the patient's participation in the study